Table 2.
2006 | 2007 and 2008 | |
---|---|---|
Non-Coverage: | ||
ARBs | 3.9% (341) | 7.4% (242) |
Cholinesterase inhibitors | 2.3% (686) | 0.4% (39) |
Opioids | 8.7% (987) | 0.9% (26) |
Osteoporosis medications | 0.4% (74) | 0.3% (16) |
Antidepressants | 4.9% (2,616) | 1.4% (266) |
Antipsychotics | 0.4% (127) | 0.01% (1) |
If Covered, PA and/or Step Therapy Was Required: | ||
ARBs | 3.4% (289) | 37.4% (1,268) |
Cholinesterase inhibitors | 13.5% (3,990) | 1.1% (105) |
Opioids | 5.7% (604) | 10.4% (344) |
Osteoporosis medications | 4.4% (799) | 9.9% (521) |
Antidepressants | 1.9% (984) | 8.8% (1,715) |
Antipsychotics | 12.8% (4,303) | 3.5% (413) |
Note: We exclude individuals who used more than one medication in the class in the 100 days before randomization to a new plan. Current medication users for 2007 and 2008 were pooled.